Aft, Forsyth & Company, Inc. Amgen Inc Transaction History

Aft, Forsyth & Company, Inc.

$199 Million
Q3 2024

A detailed history of Aft, Forsyth & Company, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Aft, Forsyth & Company, Inc. holds 4,235 shares of AMGN stock, worth $1.19 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

4,235

Previous 3,935 7.62%

Holding current value

$1.19 Million

Previous $1.23 Million 10.98%

% of portfolio

0.68%

Previous 0.64%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $92,814 - $101,214	300 Added 7.62%	4,235 $1.36 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $90,648 - $110,161	345 Added 9.61%	3,935 $1.23 Million
Q1 2024 Apr 30, 2024	SELL	$268.87 - $324.56 $72,326 - $87,306	-269 Reduced 6.97%	3,590 $1.02 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $6,392 - $7,211	25 Added 0.65%	3,859 $1.11 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $54,881 - $68,136	251 Added 7.01%	3,834 $1.03 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $45,425 - $53,714	-212 Reduced 5.59%	3,583 $795,000
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $16,708 - $20,364	-74 Reduced 1.91%	3,795 $917,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $5,267 - $6,693	-23 Reduced 0.59%	3,869 $1.02 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1,346 - $1,518	6 Added 0.15%	3,892 $877,000
Q2 2022 Jul 28, 2022	BUY	$230.71 - $256.74 $3,460 - $3,851	15 Added 0.39%	3,886 $946,000
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $30,039 - $33,232	-137 Reduced 3.42%	3,871 $936,000
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $62,448 - $71,466	-314 Reduced 7.27%	4,008 $902,000
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $31,840 - $37,305	-150 Reduced 3.35%	4,322 $919,000
Q2 2021 Jul 15, 2021	SELL	$233.58 - $259.14 $4,438 - $4,923	-19 Reduced 0.42%	4,472 $1.09 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $37,866 - $45,092	175 Added 4.05%	4,491 $1.03 Million
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $34,962 - $38,881	-149 Reduced 3.34%	4,316 $1.1 Million
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $8,901 - $10,923	45 Added 1.02%	4,465 $1.05 Million
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $148,525 - $196,985	-815 Reduced 15.57%	4,420 $896,000
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $18,921 - $24,320	100 Added 1.95%	5,235 $1.26 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $34,822 - $41,724	200 Added 4.05%	5,135 $994,000
Q2 2019 Jul 29, 2019	SELL	$166.7 - $195.41 $5,001 - $5,862	-30 Reduced 0.6%	4,935 $909,000
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $22,608 - $25,485	125 Added 2.58%	4,965 $943,000
Q3 2018 Oct 26, 2018	BUY	$185.29 - $208.89 $72,448 - $81,675	391 Added 8.79%	4,840 $1 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $34,870 - $39,167	210 Added 4.95%	4,449 $821,000
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $17,790 - $20,790	105 Added 2.54%	4,239 $723,000
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $697,777 - $779,631	4,134	4,134 $719,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aft, Forsyth & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aft, Forsyth & Company, Inc. with notifications on news.

Account

Aft, Forsyth & Company, Inc. Amgen Inc Transaction History